Sep 29, 2004 by Brian GormanCalifornia Pizza PartyCalifornia Pizza continues to signal that it's on the right track.
Sep 28, 2004 by Brian GormanCambrex's Dose of RealityThe biopharma's outlook is cloudy due to stiffer competition in biomanufacturing.
Sep 27, 2004 by Brian GormanCalifornia Calls the ShotsCalifornia is enacting environmental legislation that could shape the U.S. auto market.
Sep 27, 2004 by Brian GormanMonsanto Gets ToughThe company will have to balance diplomacy with its task of quelling piracy.
Sep 24, 2004 by Brian GormanEmisphere Wins Novartis OverEmisphere warrants close attention, although massive profits are not in the near-term cards.
Sep 24, 2004 by Brian GormanHere Comes the SunSolar power adoption looks ready to grow -- a trend investors should cash in on.
Aug 10, 2004 by Brian GormanBiotech Cost ControlWill the high cost of therapies slow sales in the sector?
Aug 3, 2004 by Brian GormanPAREXEL Gets LeanerPAREXEL continues to improve operating performance, but that might not affect its stock price.
Aug 2, 2004 by Brian GormanToyota Stays PracticalToyota is racking up huge earnings, but its decision to drop its roadster convertible could be a mistake.
Aug 2, 2004 by Brian GormanWill Lipitor's Certification Boost Pfizer?The FDA's ruling may help the company ward off a new threat.
Jul 30, 2004 by Brian GormanTarget Cleans HouseThe retailer unloads its Mervyn's stores, and now has some extra spending money.
Jul 30, 2004 by Brian GormanIn China, Hope for Modified SeedsChina leans toward allowing genetically modified crops, a potential windfall for Monsanto and competitors.
Jul 29, 2004 by Brian GormanExpress Scripts' Bad DayExpress Scripts joins other PBMs embroiled in legal controversy.
Jul 29, 2004 by Brian GormanBristol-Myers Bottoming Out?The company's expectations are in doubt, but investors might want to focus on its potential.
Jul 28, 2004 by Brian GormanYoung Women: McDonald's Wants YouThe company's new Chicken Selects seem to be aimed at a diet-conscious demographic.
Jul 28, 2004 by Brian GormanCardinal WatchingCardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge.
Jul 27, 2004 by Brian GormanOmnicare in a "Rough Patch"?Missed earnings expectations raise questions about its NeighborCare purchase.
Jul 27, 2004 by Brian GormanMedco's Pumped About GenericsGeneric drugs are actually helping improve Medco's margins.
Jul 26, 2004 by Brian GormanMore Dough From California Pizza?The earnings were tasty, but could rise even more in the coming quarters.
